Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60


Adolescent bystanders' perspectives of aggression in the online versus school environments.

Patterson LJ, Allan A, Cross D.

J Adolesc. 2016 Jun;49:60-7. doi: 10.1016/j.adolescence.2016.02.003. Epub 2016 Mar 20.


Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.

Vargas-Inchaustegui DA, Tuero I, Mohanram V, Musich T, Pegu P, Valentin A, Sui Y, Rosati M, Bear J, Venzon DJ, Kulkarni V, Alicea C, Pilkington GR, Liyanage NP, Demberg T, Gordon SN, Wang Y, Hogg AE, Frey B, Patterson LJ, DiPasquale J, Montefiori DC, Sardesai NY, Reed SG, Berzofsky JA, Franchini G, Felber BK, Pavlakis GN, Robert-Guroff M.

Clin Immunol. 2014 Aug;153(2):308-22. doi: 10.1016/j.clim.2014.05.008. Epub 2014 Jun 4.



Kirthi V, Temple RM, Patterson LJ.

Clin Med (Lond). 2013 Feb;13(1):117. No abstract available.


Antibodies to gp120 and PD-1 expression on virus-specific CD8+ T cells in protection from simian AIDS.

Vaccari M, Halwani R, Patterson LJ, Boasso A, Beal J, Tryniszewska E, Hryniewicz A, Venzon D, Haddad EK, El-Far M, Rosati M, Pavlakis GN, Felber BK, Al-Muhsen S, Robert-Guroff M, Sekaly RP, Franchini G.

J Virol. 2013 Mar;87(6):3526-37. doi: 10.1128/JVI.02686-12. Epub 2013 Jan 16.


Inpatient care: should the general physician now take charge?

Kirthi V, Temple RM, Patterson LJ.

Clin Med (Lond). 2012 Aug;12(4):316-9.


NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.

Vargas-Inchaustegui DA, Xiao P, Tuero I, Patterson LJ, Robert-Guroff M.

J Immunol. 2012 Aug 15;189(4):1878-85. doi: 10.4049/jimmunol.1201026. Epub 2012 Jul 13.


Is it time for a new kind of hospital physician?

Temple RM, Kirthi V, Patterson LJ.

BMJ. 2012 Apr 4;344:e2240. doi: 10.1136/bmj.e2240. No abstract available.


Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route.

Patterson LJ, Kuate S, Daltabuit-Test M, Li Q, Xiao P, McKinnon K, DiPasquale J, Cristillo A, Venzon D, Haase A, Robert-Guroff M.

Clin Vaccine Immunol. 2012 May;19(5):629-37. doi: 10.1128/CVI.00010-12. Epub 2012 Mar 21.


Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.

Xiao P, Patterson LJ, Kuate S, Brocca-Cofano E, Thomas MA, Venzon D, Zhao J, DiPasquale J, Fenizia C, Lee EM, Kalisz I, Kalyanaraman VS, Pal R, Montefiori D, Keele BF, Robert-Guroff M.

J Virol. 2012 Apr;86(8):4644-57. doi: 10.1128/JVI.06812-11. Epub 2012 Feb 15.


The "STEP-wise" future of adenovirus-based HIV vaccines.

Patterson LJ.

Curr Med Chem. 2011;18(26):3981-6. Review.


Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory.

Demberg T, Ettinger AC, Aladi S, McKinnon K, Kuddo T, Venzon D, Patterson LJ, Phillips TM, Robert-Guroff M.

Vaccine. 2011 Aug 11;29(35):6017-28. doi: 10.1016/j.vaccine.2011.06.032. Epub 2011 Jun 25.


Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia.

Brocca-Cofano E, McKinnon K, Demberg T, Venzon D, Hidajat R, Xiao P, Daltabuit-Test M, Patterson LJ, Robert-Guroff M.

Vaccine. 2011 Apr 12;29(17):3310-9. doi: 10.1016/j.vaccine.2011.02.066. Epub 2011 Mar 5.


Children's understanding of the selling versus persuasive intent of junk food advertising: implications for regulation.

Carter OB, Patterson LJ, Donovan RJ, Ewing MT, Roberts CM.

Soc Sci Med. 2011 Mar;72(6):962-8. doi: 10.1016/j.socscimed.2011.01.018. Epub 2011 Feb 23.


Rapid SIV Env-specific mucosal and serum antibody induction augments cellular immunity in protecting immunized, elite-controller macaques against high dose heterologous SIV challenge.

Patterson LJ, Daltabuit-Test M, Xiao P, Zhao J, Hu W, Wille-Reece U, Brocca-Cofano E, Kalyanaraman VS, Kalisz I, Whitney S, Lee EM, Pal R, Montefiori DC, Dandekar S, Seder R, Roederer M, Wiseman RW, Hirsch V, Robert-Guroff M.

Virology. 2011 Mar 1;411(1):87-102. doi: 10.1016/j.virol.2010.12.033. Epub 2011 Jan 14.


Genomic analysis reveals pre- and postchallenge differences in a rhesus macaque AIDS vaccine trial: insights into mechanisms of vaccine efficacy.

Palermo RE, Patterson LJ, Aicher LD, Korth MJ, Robert-Guroff M, Katze MG.

J Virol. 2011 Jan;85(2):1099-116. doi: 10.1128/JVI.01522-10. Epub 2010 Nov 10.


Binding between Crossveinless-2 and Chordin von Willebrand factor type C domains promotes BMP signaling by blocking Chordin activity.

Zhang JL, Patterson LJ, Qiu LY, Graziussi D, Sebald W, Hammerschmidt M.

PLoS One. 2010 Sep 23;5(9):e12846. doi: 10.1371/journal.pone.0012846.


Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.

Xiao P, Zhao J, Patterson LJ, Brocca-Cofano E, Venzon D, Kozlowski PA, Hidajat R, Demberg T, Robert-Guroff M.

J Virol. 2010 Jul;84(14):7161-73. doi: 10.1128/JVI.00410-10. Epub 2010 May 5.


Care closer to home--a changing role for physicians?

Patterson LJ.

Clin Med (Lond). 2010 Feb;10(1):4-5. No abstract available.


Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge.

Demberg T, Boyer JD, Malkevich N, Patterson LJ, Venzon D, Summers EL, Kalisz I, Kalyanaraman VS, Lee EM, Weiner DB, Robert-Guroff M.

J Virol. 2008 Nov;82(21):10911-21. doi: 10.1128/JVI.01129-08. Epub 2008 Aug 27.


Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development.

Patterson LJ, Robert-Guroff M.

Expert Opin Biol Ther. 2008 Sep;8(9):1347-63. doi: 10.1517/14712598.8.9.1347 . Review.


Comparative study of Tat vaccine regimens in Mauritian cynomolgus and Indian rhesus macaques: influence of Mauritian MHC haplotypes on susceptibility/resistance to SHIV(89.6P) infection.

Florese RH, Wiseman RW, Venzon D, Karl JA, Demberg T, Larsen K, Flanary L, Kalyanaraman VS, Pal R, Titti F, Patterson LJ, Heath MJ, O'Connor DH, Cafaro A, Ensoli B, Robert-Guroff M.

Vaccine. 2008 Jun 19;26(26):3312-21. doi: 10.1016/j.vaccine.2008.03.100. Epub 2008 Apr 30.


Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques.

Patterson LJ, Beal J, Demberg T, Florese RH, Malkevich N, Venzon D, Aldrich K, Richardson E, Kalyanaraman VS, Kalisz I, Lee EM, Montefiori DC, Robey FA, Robert-Guroff M.

Virology. 2008 May 10;374(2):322-37. doi: 10.1016/j.virol.2007.12.037. Epub 2008 Feb 5.


A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.

Demberg T, Florese RH, Heath MJ, Larsen K, Kalisz I, Kalyanaraman VS, Lee EM, Pal R, Venzon D, Grant R, Patterson LJ, Korioth-Schmitz B, Buzby A, Dombagoda D, Montefiori DC, Letvin NL, Cafaro A, Ensoli B, Robert-Guroff M.

J Virol. 2007 Apr;81(7):3414-27. Epub 2007 Jan 17.


The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.

Patterson LJ, Gering M, Eckfeldt CE, Green AR, Verfaillie CM, Ekker SC, Patient R.

Blood. 2007 Mar 15;109(6):2389-98. Epub 2006 Nov 7.


Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses.

Malkevitch NV, Patterson LJ, Aldrich MK, Wu Y, Venzon D, Florese RH, Kalyanaraman VS, Pal R, Lee EM, Zhao J, Cristillo A, Robert-Guroff M.

Virology. 2006 Sep 15;353(1):83-98. Epub 2006 Jun 30.


The "Ets" factor: vessel formation in zebrafish--the missing link?

Patterson LJ, Patient R.

PLoS Biol. 2006 Jan;4(1):e24. No abstract available.


A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

Gómez-Román VR, Florese RH, Patterson LJ, Peng B, Venzon D, Aldrich K, Robert-Guroff M.

J Immunol Methods. 2006 Jan 20;308(1-2):53-67. Epub 2005 Nov 28.


Enhanced immunity and protective efficacy against SIVmac251 intrarectal challenge following ad-SIV priming by multiple mucosal routes and gp120 boosting in MPL-SE.

Pinczewski J, Zhao J, Malkevitch N, Patterson LJ, Aldrich K, Alvord WG, Robert-Guroff M.

Viral Immunol. 2005;18(1):236-43.


Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.

Gómez-Román VR, Patterson LJ, Venzon D, Liewehr D, Aldrich K, Florese R, Robert-Guroff M.

J Immunol. 2005 Feb 15;174(4):2185-9.


Scl is required for dorsal aorta as well as blood formation in zebrafish embryos.

Patterson LJ, Gering M, Patient R.

Blood. 2005 May 1;105(9):3502-11. Epub 2005 Jan 11.


Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting.

Patterson LJ, Malkevitch N, Venzon D, Pinczewski J, Gómez-Román VR, Wang L, Kalyanaraman VS, Markham PD, Robey FA, Robert-Guroff M.

J Virol. 2004 Mar;78(5):2212-21.


Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinants.

Zhao J, Lou Y, Pinczewski J, Malkevitch N, Aldrich K, Kalyanaraman VS, Venzon D, Peng B, Patterson LJ, Edghill-Smith Y, Woodward R, Pavlakis GN, Robert-Guroff M.

Vaccine. 2003 Sep 8;21(25-26):4022-35.


Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.

Patterson LJ, Malkevitch N, Pinczewski J, Venzon D, Lou Y, Peng B, Munch C, Leonard M, Richardson E, Aldrich K, Kalyanaraman VS, Pavlakis GN, Robert-Guroff M.

J Virol. 2003 Aug;77(16):8607-20.


What is the Commission for Health Improvement?

Patterson LJ, Lilburne C.

Postgrad Med J. 2003 Jun;79(932):303-5. No abstract available.


Insertion of HIV-1 genes into Ad4DeltaE3 vector abrogates increased pathogenesis in cotton rats due to E3 deletion.

Patterson LJ, Prince GA, Richardson E, Alvord WG, Kalyan N, Robert-Guroff M.

Virology. 2002 Jan 5;292(1):107-13.


Formation of HIV-1 envelope-hepatitis B core antigen hybrids with high affinity for CD4.

Patterson LJ, Aberdeen A, Kone J, Haben M, Raymond M, Berkower I.

Biochem Biophys Res Commun. 2001 Jul 20;285(3):639-43.


A conformational C4 peptide polymer vaccine coupled with live recombinant vector priming is immunogenic but does not protect against rectal SIV challenge.

Patterson LJ, Robey F, Muck A, Van Remoortere K, Aldrich K, Richardson E, Alvord WG, Markham PD, Cranage M, Robert-Guroff M.

AIDS Res Hum Retroviruses. 2001 Jun 10;17(9):837-49.


Cross-protection in NYVAC-HIV-1-immunized/HIV-2-challenged but not in NYVAC-HIV-2-immunized/SHIV-challenged rhesus macaques.

Patterson LJ, Peng B, Abimiku AG, Aldrich K, Murty L, Markham PD, Kalyanaraman VS, Alvord WG, Tartaglia J, Franchini G, Robert-Guroff M.

AIDS. 2000 Nov 10;14(16):2445-55.


Latex anaphylaxis causing heart block: role of ranitidine.

Patterson LJ, Milne B.

Can J Anaesth. 1999 Aug;46(8):776-8.


Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.

Buge SL, Murty L, Arora K, Kalyanaraman VS, Markham PD, Richardson ES, Aldrich K, Patterson LJ, Miller CJ, Cheng SM, Robert-Guroff M.

J Virol. 1999 Sep;73(9):7430-40.


Self-regulation: what is the future?

Patterson LJ.

Hosp Med. 1999 Jan;60(1):8-9. No abstract available.


Vaccine protection against a heterologous, non-syncytium-inducing, primary human immunodeficiency virus.

Robert-Guroff M, Kaur H, Patterson LJ, Leno M, Conley AJ, McKenna PM, Markham PD, Richardson E, Aldrich K, Arora K, Murty L, Carter L, Zolla-Pazner S, Sinangil F.

J Virol. 1998 Dec;72(12):10275-80.


Hyper-antigenic variation occurs with human rhinovirus type 17.

Patterson LJ, Hamparian VV.

J Virol. 1997 Feb;71(2):1370-4. Erratum in: J Virol 1997 Apr;71(4):3363.


Proton spectroscopy of human brain: effects of age and sex.

Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Patterson LJ, Doraiswamy PM, McDonald WM.

Prog Neuropsychopharmacol Biol Psychiatry. 1994 Oct;18(6):995-1004.


Hypercortisolemia and hippocampal changes in depression.

Axelson DA, Doraiswamy PM, McDonald WM, Boyko OB, Tupler LA, Patterson LJ, Nemeroff CB, Ellinwood EH Jr, Krishnan KR.

Psychiatry Res. 1993 May;47(2):163-73.


Thrombolytic treatment for elderly patients.

Hajela VP, Singh SK, Patterson LJ.

BMJ. 1992 Nov 21;305(6864):1294. No abstract available.


In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.

Axelson DA, Doraiswamy PM, Boyko OB, Rodrigo Escalona P, McDonald WM, Ritchie JC, Patterson LJ, Ellinwood EH Jr, Nemeroff CB, Krishnan KR.

Psychiatry Res. 1992 Oct;44(1):63-70.


Formal appraisal of junior medical staff.

Patterson LJ, Hajela VP.

J R Coll Physicians Lond. 1992 Oct;26(4):383-4. No abstract available.

Supplemental Content

Loading ...
Support Center